Press Releases

Emmaus Life Sciences Announces Agreement for Evaluation of L-glutamine for Pancreatic Cancer

Aug 31, 2026 9:30am EDT

Emmaus Life Sciences Reports Quarterly Financial Results

Aug 14, 2026 4:11pm EDT

Emmaus Life Sciences Reports Quarterly Financial Results

May 15, 2026 3:51pm EDT

Emmaus Life Sciences Reports Annual Financial Results

Mar 30, 2026 10:00pm EDT

Emmaus Life Sciences Announces Strategic Transaction

Dec 30, 2025 4:30pm EST

Emmaus Life Sciences Reports Quarterly Financial Results

Nov 14, 2025 3:57pm EST

Emmaus Life Sciences Reports Quarterly Financial Results

Aug 14, 2025 3:13pm EDT

Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements

Jun 26, 2025 9:30am EDT

Emmaus Life Sciences Reports Quarterly Financial Results

May 15, 2025 4:30pm EDT

Emmaus Life Sciences Reports 2024 Financial Results

Apr 14, 2025 6:25pm EDT